2020 Healthcare Industry Trends

  Global Surgical Retractors Market Overview: The  Global Surgical Retractors Market  held a market value of USD 1,103 Million in 2017 and is projected to grow at a CAGR of 7.8% over the forecast period. Increasing number of surgical procedures leading to increase demand of surgical retractors. Surgical retractors are one of the important surgical instruments which is used to separate the edges of the wound or surgical incision.   Due to increasing prevalence of obesity across the globe many of the companies are in the race to introduce better treatment for obesity. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market. Additionally, the growing research and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.

  Integrated Operating Room Management Systems Market Highlights: Rapid expansion of the global healthcare sector has resulted in increased efficiency of several medical processes. Operating room integration systems offers consolidation of large volumes of data and allows control from a central command station, thus increasing efficiency in the operating room. Market Research Future's detailed analysis of the  global integrated operating room management systems market  has led to several key findings which offer conclusive information regarding the growth of the market over the forecast period from 2018 to 2023. In 2017, at the start of the forecast period, the integrated operating room management systems market was valued at USD 766.88 Mn and is projected to expand at an optimistic CAGR of 10% during the review period. Following this trajectory, the integrated operating room management systems market is likely to reach a market value of USD 1,521.81 by 2023. Notably, risk factors

  Bioanalytical Testing Services Market  Overview The  global bioanalytical testing services market  is expected to touch a valuation of USD 1,867.30 million by 2023, as per the latest report by Market Research Future (MRFR). High needs of blockbuster drugs to treat chronic diseases is one of the major factors predicted to drive the market growth over the forecast period (2018-2023). Rising research and development activities conducted in biotechnology and pharmaceutical sectors can spur market growth. Increasing development of biologics can induce market demand over the forecast period. Patent expiry of various drugs and need for them to expedite clinical trials can positively impact the bioanalytical testing services market. Outsourcing of testing services to contract research organizations (CROs) in developing economies to curtail operational expenditure costs can propel market growth over the forecast period. Rising prevalence of cancer and other chronic ailments which require bloc

  Global Eye Health Supplements Market Overview Global Eye Health Supplements Market  is estimated to be valued at USD 9,355.09 Million by 2025 and is expected to register a CAGR of 6.36% during the forecast period 2019–2025. Key Findings of the Study The Global Eye Health Supplements Market is projected to reach over USD 9,355.09 million by 2025 at a 6.36% CAGR during the review period of 2019 to 2025. Based on indication, the age-related macular degeneration (AMD) segment accounted for the largest market share of 22.5% in 2018. Based on product type, the antioxidant segment accounted for the largest market share of 38.6% in 2018. Based on supplement type, the vitamins accounted for the largest market share of 42.7% in 2018. Based on distribution channel, the online pharmacy segment accounted for the largest market share of 44.7% in 2018. Key manufacturers in the eye health supplements market, such as Bausch & Lomb, Incorporated, Alcon, Pfizer, Inc., Amway, are adopting geographic

  Global Avian Influenza Vaccine Market Overview Global Avian Influenza Vaccine Market  is expected to register a CAGR of 7.25% during the forecast period, with a market value of USD 735.22 Million till 2025. Avian influenza or bird flu is an infection caused in birds due to the influenza type A virus. These viruses naturally occur among wild aquatic birds and can easily infect domestic poultry, other birds, and animal species. Key Findings of the Study The Global Avian Influenza Vaccine Market is estimated to reach  USD 735.22 Million by 2025  at a  CAGR of 7.25%  during the assessment period The APAC & Middle East accounted for the largest share of the global avian influenza vaccine market due to the increasing prevalence of avian influenza Based on strain, the H5 segment accounted for the largest market share of 62.5% in 2018 Based on application, the chicken segment accounted for the largest market share of 36.1% in 2018 Intended Audience Pharmaceutical companies Biotechnology

  Global Lymphedema Diagnostics Market Overview According to MRFR analysis, the  global lymphedema diagnostics market  is expected to register a CAGR of ~7.1% during the forecast period of 2019 to 2025 and was valued at USD 22.6 million in 2018. Lymphatic obstruction or lymphedema is a long-term condition where the excess fluid forms in the body tissue and causes swelling commonly called edema. It develops due to the damaged lymphatic system. Sometimes it also develops after the treatment of breast cancer. The growth of the global lymphedema diagnostics market is determined by numerous factors such as increasing incidence of cancer, high prevalence of lymphedema, and the adoption of new diagnostic modalities. However, the short half-life of radiopharmaceuticals and the high cost of diagnostic tests is projected to restrain the growth of the market during the forecast period. The global lymphedema diagnostics market is currently dominated by several market players. The key players are i

Global Somatostatin Analogs Market Overview According to MRFR analysis,  Somatostatin Analogs Market  is expected to register a CAGR of 6.8% during the forecast period of 2019 to 2025 and is anticipated to reach USD 8,640 Million by 2025. The growth of the global somatostatin analogs market is driven by various factors such as increasing research & development activity in the somatostatin analogs market and increasing numbers of players involved in the development of generic versions of somatostatin analogs. Some of the key companies operating in this market are Nodysis Pharma, United Biotech, Wockhardt, Neiss, Sun Pharma, and Ferring Holding SA, among others. In addition, the rising incidence rate of the NETs; and increasing efforts by government bodies and public and private organizations to increase awareness about Acromegaly are some of the other factors for the growth of the somatostatin analogs market. The report for Global market by Market Research Future comprises of extens

  Global Vitiligo Treatment Market Overview According to MRFR analysis,  Vitiligo Treatment Market  is expected to register a CAGR of 5.6% during the forecast period of 2019 to 2025 and was valued at USD 1.22 Billion in 2018 Vitiligo is a skin disorder that causes white patches to appear on the skin. These patches occur because the melanocytes are destroyed, leaving areas of skin with no pigment at all. It can affect any skin part of the body. The growth of the global vitiligo treatment market is driven by various factors such as emerging therapies for skin disorders, increasing healthcare expenditure, lifestyle changes. However, the lack of skilled professionals is expected to curb the growth of the global vitiligo treatment market. Key Players Some of the Key Players in the Global Vitiligo Treatment Market are  Bausch Health Companies Inc. (Laval, Quebec), STRATA Skin Sciences (Horsham, PA), Reddy’s Laboratories Ltd. (India), Allergan, Inc. (Dublin, Coolock), Clinuvel Pharmaceuticals

  Global Stem Cell Banking Market Highlights: According to MRFR analysis,  Stem Cell Banking Market   is expected to register a  CAGR of 9.8%  during the forecast period of  2019 to 2025  and is expected to reach  USD 12,056.7 Million by 2025. Global Stem Cell Banking Market Research Report: By Cell Type (Umbilical Cord Stem Cells, Adult Stem Cells, Embryonic Stem Cells), By Bank Type (Private Banks, Public Banks, Hybrid Banks) and By Application (Thalassemia, Cerebral Palsy, Diabetes, Leukemia, Autism, Others) – Forecast to 2025 Stem cells (SC) are a class of undifferentiated biological cells of a multicellular organism that have the ability to produce indefinite cells of the same type, from which certain types of cells (proliferation and replication) can be produced by differentiation in the body through early life and growth. The stem has the potential to develop into several different cell types, from muscle cells to brain cells. Factors representing the growth of the market are ri

  Global Lymphedema Treatment Market – Overview The increasing prevalence of cancer is expected to drive the  Global Lymphedema Treatment Market . The strong clinical pipeline is likely to boost the market growth. Market players like HERANTIS PHARMA PLC, are developing curative treatment of secondary lymphedema—Lymfactin. Lymfactin is the world’s first and only clinical-stage gene therapy against lymphedema. The market potential of the drug is estimated to be around USD 650 Million Key Players 3A Health Care (Italy) Bio Compression Systems, Inc. (US) Devon Medical Products (US) HERANTIS PHARMA PLC (Finland) Lohmann & Rauscher (Germany) Mego Afek Ltd (US) SIGVARIS (Switzerland) Tactile Systems Technology Inc. (US) Wright Therapy Products (BSN Medical) (Germany)  The report for Global market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders

  New-Born Screening Market Overview Market Highlights The   Global New-Born Screening Market   is expected to register a  CAGR of   13.33%  during the forecast period with a market value of  USD 1545.98 Million till 2025.  Newborn screening is the practice of testing every newborn for some harmful or possibly fatal disorders that are not otherwise obvious at birth. New-born screening involves the use of various devices for the screening procedure. Global New-Born Screening Market: Information by Product (Reagents and Assay Kits and Instruments), by Technology (Tandem Mass Spectrometry, Immunoassays and Enzymatic Assays, Hearing Screening Technology, DNA Assays and Pulse Oximetry), by Test Type (Dry Blood Spot Test, Hearing Screening Test and Critical Congenital Heart Disease (CCHD) Test), by End User (Hospitals, Maternity and Specialty Clinics and Diagnostic Centers) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025 Key Findings of th